Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Competition waiting on FDA approval

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Aug 13, 2021 7:36pm

281 Views

Post# 33705196

RE:RE:RE:Competition waiting on FDA approval

I'm fairly confident that Theralase will do far better than Viciniums's less than 17% CR rate at 12 months. Maybe even 4 times better.

enriquesuave wrote: SESN hit its yearly high of 6.04 today and yearly low of 0.70 following CRL from FDA. Maybe they know we have the goods and no one else compares. Just saying. All IMO. Feel sorry for SESN shareholders

<< Previous

Bullboard Posts

Next >>

Mullen Group: Navigates market challenges towards success